[go: up one dir, main page]

12/15-Lipoxygenase regulates the inflammatory response to bacterial products in vivo

J Immunol. 2008 Nov 1;181(9):6514-24. doi: 10.4049/jimmunol.181.9.6514.

Abstract

The peritoneal macrophage (Mphi) is the site of greatest 12/15-lipoxygenase (12/15-LOX) expression in the mouse; however, its immunoregulatory role in this tissue has not been explored. Herein, we show that 12/15-LOX is expressed by 95% of resident peritoneal CD11b(high) cells, with the remaining 5% being 12/15-LOX(-). 12/15-LOX(+) cells are phenotypically defined by high F4/80, SR-A, and Siglec1 expression, and enhanced IL-10 and G-CSF generation. In contrast, 12/15-LOX(-) cells are a dendritic cell population. Resident peritoneal Mphi numbers were significantly increased in 12/15-LOX(-/-) mice, suggesting alterations in migratory trafficking or cell differentiation in vivo. In vitro, Mphi from 12/15-LOX(-/-) mice exhibit multiple abnormalities in the regulation of cytokine/growth factor production both basally and after stimulation with Staphylococcus epidermidis cell-free supernatant. Resident adherent cells from 12/15-LOX(-/-) mice generate more IL-1, IL-3, GM-CSF, and IL-17, but less CCL5/RANTES than do cells from wild-type mice, while Staphylococcus epidermidis cell-free supernatant-elicited 12/15-LOX(-/-) adherent cells release less IL-12p40, IL-12p70, and RANTES, but more GM-CSF. This indicates a selective effect of 12/15-LOX on peritoneal cell cytokine production. In acute sterile peritonitis, 12/15-LOX(+) cells and LOX products were cleared, then reappeared during the resolution phase. The peritoneal lavage of 12/15-LOX(-/-) mice showed elevated TGF-beta1, along with increased immigration of monocytes/Mphi, but decreases in several cytokines including RANTES/CCL5, MCP-1/CCL2, G-CSF, IL-12-p40, IL-17, and TNF-alpha. No changes in neutrophil or lymphocyte numbers were seen. In summary, endogenous 12/15-LOX defines the resident MPhi population and regulates both the recruitment of monocytes/Mphi and cytokine response to bacterial products in vivo.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid / biosynthesis
  • 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid / physiology
  • Acute Disease
  • Animals
  • Arachidonate 12-Lipoxygenase / biosynthesis
  • Arachidonate 12-Lipoxygenase / deficiency
  • Arachidonate 12-Lipoxygenase / physiology*
  • Arachidonate 15-Lipoxygenase / biosynthesis
  • Arachidonate 15-Lipoxygenase / deficiency
  • Arachidonate 15-Lipoxygenase / physiology*
  • Cells, Cultured
  • Cytokines / biosynthesis*
  • Cytokines / metabolism
  • Cytokines / physiology
  • Hydroxyeicosatetraenoic Acids / biosynthesis
  • Hydroxyeicosatetraenoic Acids / physiology
  • Immunophenotyping
  • Inflammation Mediators / metabolism
  • Inflammation Mediators / physiology*
  • Macrophages, Peritoneal / enzymology
  • Macrophages, Peritoneal / microbiology
  • Macrophages, Peritoneal / pathology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Peritonitis / enzymology*
  • Peritonitis / immunology
  • Peritonitis / microbiology*
  • Staphylococcal Infections / enzymology*
  • Staphylococcal Infections / immunology
  • Staphylococcal Infections / pathology*
  • Staphylococcus epidermidis / immunology*
  • Staphylococcus epidermidis / metabolism

Substances

  • 12-15-lipoxygenase
  • Cytokines
  • Hydroxyeicosatetraenoic Acids
  • Inflammation Mediators
  • 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
  • 11-hydroxy-5,8,12,14-eicosatetraenoic acid
  • 8-hydroxyeicosatetraenoic acid
  • Arachidonate 12-Lipoxygenase
  • Arachidonate 15-Lipoxygenase